Finance & economics | Free exchange

An incurable disease

A new book explains how health care can become both more expensive and more affordable

|5 min read

HEALTH-CARE expenditure in America is growing at a disturbing rate: in 1960 it was just over 5% of GDP, in 2011 almost 18%. By 2105 the number could reach 60%, according to William Baumol of New York University’s Stern School of Business. Incredible? It is simply the result of extrapolating the impact of a phenomenon Mr Baumol has become famous for identifying: “cost disease”. His new book* gives a nuanced diagnosis, offerings both a vision of a high-cost future and a large dose of optimism. The cost disease may be incurable, but it is also survivable—if treated correctly.

This article appeared in the Finance & economics section of the print edition under the headline “An incurable disease”

Heading out of the storm

From the September 29th 2012 edition

Discover stories from this section and more in the list of contents

Explore the edition
illustration of a map of Africa with a large pixelated cursor pointing at Zambia, which is highlighted in yellow

Want to be a good explorer? Study economics

The battle to reduce risk has shaped centuries of ventures

Illustration of a hand pushing a jagged black arrow upward against a red background. The Jane Street logo appears to be rolling down the arrow in the opposite direction.

Jane Street is chucked out of India. Other firms should be nervous

Around the world, marketmakers now face extra scrutiny


A man looks at an advertisement for the Nippon Individual Savings Account (NISA) displayed at a branch of Nomura Securities Co., a unit of Nomura Holdings Inc., in the Kichijoji area of Tokyo, Japan.

Japan has been hit by investing fever

Will old folk catch the bug?


Don’t invest through the rearview mirror

Markets are supposed to look forward; plenty of investors look back instead

Trump’s trade deals try a creative way to hobble China

To appease the world’s biggest market, countries must anger the world’s biggest trader

The great dealmaker is conspicuously short of trade deals

Donald Trump issues threats—and grants deadline extensions